Publication:
Comparing individual angiotensin-converting enzyme inhibitors with losartan in the risk of hospitalization for pneumonia and related mortality: A nationwide cohort study

cris.lastimport.scopus2025-05-08T22:14:42Z
cris.virtual.departmentInternal Medicine-NTUHen_US
cris.virtual.departmentInternal Medicineen_US
cris.virtual.departmentInternal Medicine-NTUHen_US
cris.virtual.departmentInternal Medicineen_US
cris.virtual.departmentInternal Medicineen_US
cris.virtual.departmentInternal Medicine-NTUHen_US
cris.virtual.orcid0000-0001-7614-3903en_US
cris.virtual.orcid0000-0003-0024-6177en_US
cris.virtual.orcid0000-0002-7949-7253en_US
cris.virtualsource.department60a83473-504f-405f-b816-44de2a0c7536
cris.virtualsource.department60a83473-504f-405f-b816-44de2a0c7536
cris.virtualsource.departmenteaa784d1-77b0-4d14-8f15-4c075f7af612
cris.virtualsource.departmenteaa784d1-77b0-4d14-8f15-4c075f7af612
cris.virtualsource.department94c9b3c0-e452-4be7-b2f3-4979b0a56477
cris.virtualsource.department94c9b3c0-e452-4be7-b2f3-4979b0a56477
cris.virtualsource.orcid60a83473-504f-405f-b816-44de2a0c7536
cris.virtualsource.orcideaa784d1-77b0-4d14-8f15-4c075f7af612
cris.virtualsource.orcid94c9b3c0-e452-4be7-b2f3-4979b0a56477
dc.contributor.authorCHIA-HSUIN CHANGen_US
dc.contributor.authorJOU-WEI LINen_US
dc.contributor.authorSHENG-YUAN RUANen_US
dc.contributor.authorLee Y.-C.en_US
dc.contributor.authorWu L.-C.en_US
dc.contributor.authorLin M.-S.en_US
dc.contributor.authorLai M.-S.en_US
dc.date.accessioned2020-10-15T03:57:51Z
dc.date.available2020-10-15T03:57:51Z
dc.date.issued2015
dc.description.abstractBACKGROUND
dc.identifier.doi10.1097/HJH.0000000000000438
dc.identifier.issn0263-6352
dc.identifier.pmid25479025
dc.identifier.scopus2-s2.0-84922475017
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84922475017&doi=10.1097%2fHJH.0000000000000438&partnerID=40&md5=61b09bc9822b8490e518ee5da427e731
dc.identifier.urihttps://scholars.lib.ntu.edu.tw/handle/123456789/517126
dc.publisherLippincott Williams and Wilkins
dc.relation.ispartofJournal of Hypertension
dc.relation.journalissue3
dc.relation.journalvolume33
dc.relation.pages634-643
dc.subject.classification[SDGs]SDG3
dc.subject.othercaptopril; dipeptidyl carboxypeptidase inhibitor; enalapril; fosinopril; imidapril; lisinopril; losartan; perindopril; ramipril; angiotensin receptor antagonist; captopril; dipeptidyl carboxypeptidase inhibitor; enalapril; losartan; ramipril; adult; Article; cohort analysis; dose response; female; hospitalization; human; hypertension; maintenance drug dose; major clinical study; male; meta analysis (topic); middle aged; mortality; outcome assessment; pneumonia; priority journal; sensitivity analysis; statistical significance; treatment duration; aged; comparative study; hospitalization; incidence; pneumonia; risk; Taiwan; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cohort Studies; Enalapril; Female; Hospitalization; Humans; Incidence; Losartan; Male; Middle Aged; Pneumonia; Ramipril; Risk; Taiwan
dc.titleComparing individual angiotensin-converting enzyme inhibitors with losartan in the risk of hospitalization for pneumonia and related mortality: A nationwide cohort studyen_US
dc.typejournal articleen
dspace.entity.typePublication

Files